Find Academic Supervisors

Chow LeeView profile

Professor

• Cancer Biology
• RNA Biochemistry and Biology
• Natural Products Drug Discovery
• +3 more

Dr. Chow Lee is a Professor in the Department of Biochemistry and Molecular Biology at the University of Northern British Columbia (UNBC). He holds a PhD from Flinders University and a BSc (Hons I) from the University of New South Wales. His research focuses on cancer biology, RNA biochemistry, natural products drug discovery, and polysaccharide science. He has pioneered biochemistry and molecular biology programs at UNBC and collaborates extensively on isolating bioactive compounds from BC’s fungal resources. Research Interests: Cancer biology and oncogenic RNA-protein interactions Discovery of medicinal compounds from BC mushrooms (e.g., anti-proliferative, immunostimulatory agents) Role of APE1 in RNA metabolism and DNA repair Zebrafish models for studying RNA granules and drug mechanisms Publications Trends: Over 50 peer-reviewed articles since 1998, with recent emphasis on natural products from fungi (e.g., Echinodontium tinctorium, Inonotus obliquus) and RNA-protein interactions in cancer pathways. Key contributions include identifying APE1’s role in RNA processing and discovering polysaccharide-based anti-inflammatory agents. Supervision & Grants: Actively mentors students in MSc/PhD programs in Biochemistry and Health Sciences. Served on grant review panels for national/international agencies. Collaborates with UNBC colleagues in cross-disciplinary drug discovery projects. Labs & Teams: Leads a research lab investigating RNA metabolism and natural product pharmacology. Engages with BC’s biodiversity to identify novel therapeutic compounds, particularly from northern BC mushrooms.

Alejandro R. ChadeView profile

Professor

• Cardiovascular Physiology
• Renal Disease Mechanisms
• Microcirculatory Function
• +3 more

Alejandro R. Chade, MD, is a Professor of Medical Pharmacology and Physiology at the University of Missouri School of Medicine and a NextGen Precision Health Investigator. His research focuses on cardiovascular and renal physiologic imaging, microcirculatory function, and mechanisms of renal and cardiac disease. Dr. Chade’s laboratory develops translational swine models of chronic kidney disease (CKD) and hypertension, leveraging advanced imaging techniques such as multi-detector CT and echocardiography to study renal and cardiac function. His work also explores novel therapeutic strategies targeting the renal and cardiac microcirculation to mitigate inflammation and improve organ function. Education: MD from Universidad Nacional de Cuyo (1996), Cardiology Residency and Fellowship at Hospital Lagomaggiore (2001), and postdoctoral training at the Mayo Clinic (2005). He has held roles at the University of Mississippi Medical Center before joining the University of Missouri. Research Interests include mechanisms linking CKD to cardiovascular disease, imaging-based diagnostics, and drug delivery systems for targeted therapies. His lab investigates macrophage polarization, NF-kB signaling pathways, and the role of mitochondrial DNA in renal injury. Key Awards: American Heart Association Established Investigator Award, Mid-Career Award, and numerous travel and recognition awards for hypertension and renal research. Publications focus on swine models, renal-cardiac crosstalk, and VEGF-based therapies, with high-impact contributions to American Journal of Physiology and Hypertension . Labs/Teams: Leads the NextGen Precision Health Initiative, collaborating on translational research to bridge basic science and clinical applications.

• Skeletal Muscle Regeneration
• Neurovascular Tissue Regeneration
• Biomaterials for Soft Tissue Applications
• +3 more

Aaron B. Morton is an Assistant Professor in Kinesiology and Sport Management at Texas A&M University, directing the Soft Tissue Regeneration and Applied Biomaterials (STRAB) Laboratory. He holds a Ph.D. in Exercise Physiology from the University of Florida (2018) and prior degrees from the University of West Florida and Harding University. His research focuses on skeletal muscle regeneration, neurovascular tissue interactions, and inorganic biomaterials for soft tissue applications, with emphasis on biomaterial development for muscle injuries and dystrophy treatment. Key research grants include a $495,972 TAMU Advancing Discovery award (2023–2025) and an NIH Loan Repayment Award for Pediatric Research (2020–2022). He has authored patents on biomaterials for stem cell dispersion and muscle treatment methods. Teaching includes KINE427 (Therapeutic Principles) and KINE433 (Exercise Physiology). Notable awards include the Microcirculatory Society Pappenheimer Postdoctoral Travel Award (2022) and multiple poster awards at physiology conferences. His work bridges biomechanical engineering with clinical applications, emphasizing translational research in regenerative therapies.

Abele DonatiView profile

Professor

• Critical Care Medicine
• Anesthesiology
• Sepsis Management
• +3 more

Prof. Abele Donati is a full professor at the Polytechnic University of Marche (UNIVPM) within the School of Medicine and Surgery , specifically in the Department of Biomedical Sciences and Public Health . His clinical practice is based at Ospedali Riuniti Umberto I - Clinica di Anestesia e Rianimazione Generale Respiratoria e del Trauma Maggiore in Ancona, Italy. Research Focus: Critical care medicine, sepsis, microcirculation, anesthesia, and respiratory failure Key Contributions: Expertise in hemodynamic monitoring, antibiotic resistance, ECMO, and perioperative medicine Publications Trends: Recent work emphasizes antimicrobial therapy for multidrug-resistant pathogens, microcirculatory dysfunction in sepsis, critical care pharmacogenetics, and advanced monitoring techniques during surgeries. His studies frequently involve multicenter collaborations and clinical trials. Contact: Email available at a.donati@univpm.it

• Cardiovascular Medicine
• Coronary Microvascular Dysfunction
• Myocardial Infarction Pathophysiology
• +3 more

Dr. Stuart Hood is an Honorary Senior Lecturer at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health and the Cardiology Department at the Royal Alexandra Hospital. His expertise focuses on coronary microvascular dysfunction, myocardial infarction pathophysiology, and interventional cardiology. He has contributed to numerous studies on fractional flow reserve (FFR), stent optimization, and coronary artery disease management. Research interests include the interplay between coronary microvascular function and atherosclerosis, as well as outcomes in patients with non-obstructive coronary arteries. His work integrates clinical trials (e.g., CorMicA, TARGET-FFR) and imaging techniques (e.g., MRI, cardiac CT) to improve diagnostic accuracy and patient care. Key themes in his publications address post-percutaneous coronary intervention (PCI) outcomes, risk stratification in acute myocardial infarction, and the role of systemic microvascular dysfunction in angina. His articles highlight advancements in PCI optimization, prognostic biomarkers for myocardial infarction, and the impact of diabetes on coronary thrombus formation. Dr. Hood collaborates with institutions like the British Cardiovascular Intervention Society and has presented at major conferences such as ACC.18 and the British Society of Cardiovascular Magnetic Resonance. No scientific awards or grants are explicitly listed in the provided materials. His academic contributions are centered on clinical research and translational cardiology, with a focus on improving therapeutic strategies for coronary artery disease and post-infarction care.

• Cardiology
• Cardiovascular Disease
• Interventional Cardiology
• +4 more

Dr. Peter McCartney is an Honorary Clinical Fellow at the School of Cardiovascular & Metabolic Health, University of Glasgow. His research focuses on coronary artery disease, myocardial infarction, and interventional cardiology, with particular expertise in coronary microvascular function and percutaneous coronary intervention (PCI) optimization. He has contributed to landmark trials like CorMicA and T-TIME, investigating stratified medical therapy and adjunctive therapies in cardiovascular conditions. His work spans clinical trials, systematic reviews, and meta-analyses, addressing topics such as coronary perforation management, stent optimization, and microvascular injury assessment. McCartney collaborates widely, including with colleagues at the University of Glasgow and international institutions, to advance diagnostic and therapeutic strategies in cardiovascular medicine. No scientific awards are explicitly mentioned in the provided materials. His publications emphasize patient outcomes, procedural improvements, and invasive coronary function testing. He has been involved in designing trials evaluating therapies like mineralocorticoid receptor antagonists and low-dose intracoronary alteplase. No specific grants or lab affiliations are detailed in the text.

• Angina
• Cardiovascular medicine
• Chronic total occlusion
• +5 more

Conjoint Associate Professor Tom Ford is an Interventional Cardiologist at the University of Newcastle's School of Medicine and Public Health. He serves as director of Central Heart on the Central Coast of NSW and holds appointments as the Australian National Young Ambassador to EAPCI (European Association for Percutaneous Coronary Intervention). He is also a Fellow of the Royal College of Physicians (Edinburgh) and Fellow of Cardiac Society for Australia/New Zealand (FCSANZ). Dr. Ford completed his medical training at the University of Dundee, receiving the University Medal (Captain WA Low Prize 2007). He gained the MRCP at the Royal College of Physicians in Edinburgh before emigrating to Australia in 2010. He completed his FRACP during advanced cardiology training at Prince of Wales Hospital and St George Hospital in Sydney. His subspecialty training included a three-year fellowship at Glasgow's Golden Jubilee National Hospital, the UK's highest volume center for coronary stents, where he also completed his PhD which won the prestigious Bellahouston Medal. Dr. Ford's research focuses on coronary physiology, interventional cardiology, and microvascular angina, with particular expertise in angina and ischemic heart disease. His work bridges clinical practice and research, investigating coronary vasomotor disorders, complex percutaneous coronary interventions, and chronic total occlusions. His recent publications demonstrate a strong emphasis on functional coronary angiography, coronary microvascular dysfunction assessment techniques, and the development of targeted therapies for microvascular disease. Dr. Ford has received significant recognition for his work including the Bellahouston Medal for his PhD thesis, EuroPCR Best Abstract award, and the British Cardiac Society's 'Best of the Best' Clinical Abstract award in Interventional Cardiology. His research has been published in leading cardiology journals and he has been invited faculty at major cardiology scientific sessions including the American Heart Association, European Society of Cardiology, EuroPCR, and Transcatheter Cardiovascular Therapeutics. Dr. Ford actively participates in multicenter clinical trials and registries including the CorMicA trial, TARGET-FFR study, and the Australian-New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry. His clinical practice combines advanced interventional techniques with a focus on diagnosing and managing patients with complex coronary conditions, particularly those with angina but without obstructive coronary artery disease.

Ranjan DashView profile

Professor

• Computational Systems Biology
• Bioengineering
• Physiology
• +5 more

Ranjan Dash is a Professor and Co-Director of Graduate Studies in the Joint Department of Biomedical Engineering at Marquette University and Medical College of Wisconsin. He also serves as Professor in the MCW Department of Physiology and Director of the Computational Systems Biology Laboratory (CSBL). His academic career spans prestigious institutions including Case Western Reserve University, University of Washington, and Texas A&M University where he completed postdoctoral training in computational systems biology and biofluid dynamics. Ph.D. in Computational Biofluid Dynamics, Indian Institute of Technology, Delhi, India (1998) M.Sc. in Applied Mathematics, Utkal University, Bhubaneswar, Orissa, India (1991) Dash's research focuses on computational systems biology and bioengineering with emphasis on mitochondrial, cellular and cardiovascular physiology. His work integrates mathematical modeling with experimental approaches to study cellular/mitochondrial metabolism and redox biology. Specific research areas include pulmonary and systemic microcirculatory gas exchange, physiologically-based pharmacokinetic modeling, blood-tissue solute transport, large-scale biochemical networks, cellular calcium and reactive oxygen species signaling, cardiac electrophysiology, and renal metabolism in salt-sensitive hypertension. His recent publications demonstrate a strong emphasis on computational modeling of physiological systems, particularly in the areas of mitochondrial bioenergetics, renal function in hypertension, CAR T-cell therapy modeling, and ischemia-reperfusion injury assessment. His work bridges computational approaches with experimental validation across multiple organ systems. Dean's Choice Outstanding Graduate School Educator Award (2019-2020, 2016-2017) Award of Tenure for scholarly achievements (2018) Outstanding Faculty Service Award (2015) Founding Faculty, Virtual Physiological Rat Center (2011) Marquis Who's Who in Science and Engineering (2011-2012) Dash has secured significant research funding as Principal or Co-Principal Investigator from major organizations including NIH, NSF, and Advancing a Healthier Wisconsin Endowment. His current projects focus on high salt effects on renal metabolism, computational modeling of CAR T-cell therapy, and advanced ion channel modeling. As Co-Director of Graduate Studies, he plays a key role in shaping the next generation of biomedical engineers while leading the Computational Systems Biology Laboratory. The Computational Systems Biology Laboratory under Dash's direction serves as a hub for interdisciplinary research, bringing together engineers, physiologists, and computational scientists to tackle complex problems in systems physiology and disease mechanisms.

Nikolaos TsoukiasView profile

Professor

• Computational and mathematical modeling
• Biotransport
• Signal transduction
• +3 more

Dr. Nikolaos Tsoukias is a Professor in the Department of Biomedical Engineering at Florida International University (FIU), where he leads the Vascular Physiology and Biotransport Lab . He holds a B.S. in Chemical Engineering from the National Technical University of Athens (1994) and a Ph.D. in Engineering from the University of California, Irvine (1999). After a research fellowship at Johns Hopkins University School of Medicine, he joined FIU in 2003. His research focuses on computational modeling of cardiovascular and respiratory systems, with emphasis on biotransport, signal transduction, and neuromuscular coupling. His work has been supported by the NIH and American Heart Association, yielding over 50 peer-reviewed publications and two patents. Key achievements include the 2006 Arthur C. Gyuton Award for excellence in integrative physiology. His lab explores mechanisms like neurovascular coupling in brain capillaries, ion channel regulation, and the role of pericytes in cerebral blood flow. Dr. Tsoukias is a member of the Biomedical Engineering Society, Microcirculatory Society, and American Physiological Society.

• Pediatric Cardiovascular Health
• School-Based Physical Activity Interventions
• Child Fitness and Anthropometry
• +3 more

Per Morten Fredriksen is a Professor at the Department of Nursing, Health and laboratory science within the Faculty of Health, Welfare and Organisation at the University of South-Eastern Norway. His research is primarily conducted through the Health Oriented Pedagogical Project (HOPP), a longitudinal school-based intervention program investigating physical activity and health outcomes in Norwegian children aged 6-12 years. His academic interests focus on pediatric cardiovascular health, school-based physical activity interventions, and metabolic health in children. Key research areas include establishing reference intervals for pediatric biomarkers, investigating waist-to-height ratio as a predictor of cardiometabolic health, and examining the relationship between physical activity, cognitive function, and academic performance. His work frequently employs retinal microcirculation analysis and anthropometric measurements to assess cardiovascular health in children. Analysis of recent publications reveals strong emphasis on longitudinal cohort studies within Norwegian primary schools, with particular attention to how physical activity interventions affect cardiovascular metrics, academic outcomes, and psychosocial health. The HOPP project serves as the central framework for most investigations, generating population-specific reference data while exploring intervention efficacy. Fredriksen maintains active collaborations with researchers across multiple institutions, particularly with Asgeir Mamen and Morten Lindberg. His work demonstrates consistent methodological rigor through controlled longitudinal designs and innovative measurement techniques including retinal imaging and hair biomarker analysis.

Sara BergstrandView profile

Assistant Professor

• Microcirculation
• Optical Measurement Techniques
• Translational Medicine
• +6 more

Sara Bergstrand is an Assistant Professor and Head of Unit at Linköping University's Department of Nursing and Reproductive Health (ORH), Faculty of Medicine. She directs the Graduate School of Close Care in the Southeastern Healthcare Region, focusing on interdisciplinary research at the interface of medical technology, translational medicine, and nursing science. Research spans microcirculation, optical measurement techniques, and translational applications Key projects: Early detection of pressure ulcers, hypertensive pregnancy complications, and SCAPIS Micro Teaching includes wound healing courses and supervision of nursing/medical students Her recent publications (2023-2025) analyze microcirculatory dysfunction in diabetes, pregnancy complications, and wound healing using optical spectroscopy. Awards include collective research funding from the Swedish Research Council (42.6M SEK for graduate school development). Collaborations span cardiovascular diabetology, biomedical optics, and clinical nursing implementation. Notable contributions include developing optical methods for tissue assessment and establishing translational frameworks between experimental research and clinical practice. Current initiatives focus on population-based microcirculatory risk profiling and multi-disciplinary healthcare optimization.

Dylan de LangeView profile

Professor

• Clinical Toxicology
• Intensive Care Medicine
• Infectious Diseases
• +2 more

Dylan de Lange is a Full Professor of Clinical Toxicology at the University Medical Center Utrecht , where he chairs the Dutch Poisons Information Center (DPIC). With a career spanning over two decades in UMC Utrecht, he combines clinical practice in Intensive Care Medicine with toxicology expertise, advising medical professionals on intoxication treatments through DPIC's 240,000+ annual consultations. European Registered Toxicologist (ERT) Senior Editor of Clinical Toxicology (Taylor & Francis) Board member of Postdoctoral Education in Toxicology (PET) His research focuses on: Toxicology surveillance systems Occupational hazardous material exposure Geriatric critical care outcomes Shock and sepsis mortality prediction Clinical toxicology case reporting Recent publications demonstrate his expertise in occupational toxicology epidemiology and critical care prognostication , with studies published in Critical Care and Scientific Reports . His work bridges clinical practice with academic research, particularly in infection & immunity contexts. Scientific contributions include: Editorial leadership in Clinical Toxicology Advisory roles in postdoctoral toxicology education Pioneering poison center surveillance methodologies

• Cardiovascular Medicine
• Cardiology
• Interventional Cardiology
• +3 more

Professor Hany Eteiba is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health, affiliated with the Institute of Cardiovascular & Medical Sciences. His research focuses on coronary microvascular dysfunction, myocardial infarction pathophysiology, and interventional cardiology. He has led pivotal studies such as the CorMicA trial, exploring coronary function testing in angina management. His work emphasizes translational research linking invasive hemodynamic measurements with clinical outcomes. Education: Not explicitly stated in provided text. Affiliations: Golden Jubilee National Hospital, Glasgow Research interests include coronary artery disease mechanisms, PCI optimization, and imaging biomarkers for infarct assessment. Over 60+ peer-reviewed publications span topics like fractional flow reserve (FFR), microvascular injury prognostics, and stent optimization strategies. Collaborations include multi-center trials (e.g., FAMOUS-NSTEMI) and device development for coronary interventions. Key contributions include defining microvascular resistance roles in prognosis and advancing thermodilution-based diagnostic techniques. His work bridges clinical cardiology with advanced imaging and genetic analysis to improve ischemic heart disease management.

Coral MurrantView profile

Professor

• Skeletal Muscle Physiology
• Microcirculation
• Intercellular Communication
• +4 more

Coral Murrant is a Professor and Chair at the University of Guelph's Human Biology Department, specializing in skeletal muscle metabolism, fatigue, and blood flow regulation. Her research explores intercellular communication between muscle cells and vascular endothelial/smooth muscle cells, with collaborations in reproductive physiology (spiral artery function in pregnancy) and comparative physiology (fish microcirculation). Funded by NSERC, she is a member of the American Physiological Society and Microcirculatory Society. Education: B.Sc., University of Guelph Ph.D., University of Guelph Her work focuses on how skeletal muscle metabolic activity influences microvascular function, testing vasodilatory metabolites and their mechanisms. Collaborative projects include studying spiral artery dysfunction in pre-eclampsia and vascular adaptations in amphibious fish surviving out-of-water. She leads a large integrative physiology course for 440 students. Scientific Memberships: American Physiological Society Microcirculatory Society Her research has been supported by NSERC and collaborative NSERC/CIHR grants. Graduate students advised include Charter (PhD) and Hyde-Lay (MSc).

Nicolas GuillotView profile

Assistant Professor

• Vascular Biology
• Endothelial Physiology
• Sickle Cell Disease
• +7 more

Nicolas Guillot is an Assistant Professor in the Biosciences Department at INSA Lyon, where he also serves as deputy director of the department and director of the Animal Facility. His academic journey began with a PhD in vascular biology from University Lyon 1 in 2008, followed by postdoctoral training in New York City focusing on vascular inflammation and angiogenesis in sickle cell disease. Institution: INSA Lyon Department: Biosciences Position: Assistant Professor Leadership Roles: Deputy Director of Biosciences Department, Director of Animal Facility His research centers on vascular biology, particularly the endothelial response to mechanical stress and red blood cell-endothelium interactions in sickle cell disease. He also investigates blood rheology, vascular inflammation, and the impact of metabolic conditions on vascular function. His work has important implications for understanding thrombosis, microvascular complications, and cardiovascular pathologies in chronic diseases. The trends in his recent publications (2016–2025) reveal a consistent focus on vascular and hematological pathologies, particularly sickle cell disease, blood viscosity, microvascular dysfunction, and related conditions such as diabetes and CKD. His collaborative, interdisciplinary research spans physiology, hematology, cardiology, and molecular biology, often involving international teams and appearing in high-impact journals like The Lancet Regional Health - Americas , Blood , and Frontiers in Physiology . Nicolas Guillot has made significant contributions to understanding: The role of omega-3 fatty acids in reducing platelet activity and thrombosis risk The involvement of the TGFbeta/BAMBI pathway in vascular restenosis and angiogenesis How shear forces alter endothelial lipid metabolism Increased vascular risk in diabetic patients with sickle-cell trait He teaches cardiovascular physiology and pharmacokinetics and leads research supported by multiple grants, collaborating with institutions in the USA, Germany, and the UK. He supervises research within the [VBRBC] team at INSA Lyon and oversees animal research facilities, ensuring ethical and scientific rigor in experimental models.